parameter | EFS at 3-ys | 95% CI | P-value | OS at 3-ys | 95% CI | P-value |
Whole patients | 45.7% | 36.9% - 56.7% |
| 66.7% | 57% - 77.8% |
|
Stage - I - III - IV |
100% 53.2% 17.8% |
42.6% - 66.4% 8.1% - 39.3% |
<0.001 |
100% 74.7% 23.9% |
64.4% - 86.6% 5.6% - 100% |
<0.001 |
Histology - PFH - Combined (Fetal & Embry) - Mixed (Epi & mesen) |
51%
50.8%
55.5% |
36.7% - 70.6%
33.3% - 77.4%
39.5% - 78% |
0.85 |
81.3%
70%
64% |
70.3% - 94%
51% - 94.8%
46% - 89% |
0.5 |
Metastasis - Yes - No |
18.5% 54.8% |
8.4% - 40.5% 44.5% - 67.5% |
<0.001 |
24.8% 75.2% |
5.8% - 100% 65.4% - 86.5% |
<0.001 |
AFP level - Above 100 - Below 100 |
48.3 % 28.6% |
|
0.1 |
69 % 38% |
|
0.02 |
Surgery - Yes - No |
68.6%
|
58% - 81.2%
|
<0.001 |
80.7%
|
70.6% - 92.2%
|
<0.001 |
Risk group - LR - IR - HR |
100% 55.6% 19.4% |
|
<0.001 |
100% 75.3% 37.4% |
|
0.001 |